Korman Tyler Paz 4

What Happened

Korman Tyler Paz, Chief Scientific Officer of EXOZYMES INC. (EXOZ), received a grant/award of 5,332 shares on April 1, 2026. The shares were reported at $8.44 each, for a total reported value of $45,002. This transaction is an award/acquisition (not a sale) — typically part of company compensation rather than an open-market purchase.

Key Details

• Transaction date: 2026-04-01; Filing date (Form 4): 2026-04-08.
• Price per share reported: $8.44; Total value: $45,002.
• Shares owned after transaction: Not specified in the provided filing.
• Transaction code: A (award/grant/other acquisition).
• No 10b5-1 plan, tax-withholding, or other footnotes were disclosed in the summary provided.
• Filing timeliness: Report filed 7 days after the transaction (appears late vs. the usual 2-business-day Form 4 deadline); late filings reduce the immediacy of disclosure and can attract regulatory attention if recurrent.

Context

Grants and awards are common executive compensation tools and do not necessarily indicate the insider's view of near-term stock direction. Vesting schedules or other conditions (if any) were not detailed in the supplied filing. For investors, awards are noteworthy as they increase insider stake but are less directly informative than open-market purchases or sales.